Vaccine Adjuvants Targeting Emerging and Re-emerging Livestock Infectious Disease: Boosting Stronger Immune Responses
A special issue of Vaccines (ISSN 2076-393X).
Deadline for manuscript submissions: 31 August 2024 | Viewed by 587
Special Issue Editors
Interests: vaccine adjuvants; immunomodulation; natural polysaccharides; Chinese herbal medicine
Interests: nanoadjuvants; veterinary vaccines; drug delivery carriers; bioactive materials; nanoparticles
Special Issues, Collections and Topics in MDPI journals
Interests: virus-like particles; subunit vaccine; vaccine adjuvants; nanoparticle delivery system; animal virus
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
Emerging and re-emerging infectious diseases caused by viruses, bacteria, fungi and parasites are causing significant morbidity and mortality not only in humans, but also in various livestock, including cattle, pigs, sheep, birds, and others. Increasing globalization and international trade have led to the rapid expansion of these diseases. Among numerous strategies, vaccination is the most effective approach to preventing and controlling infectious diseases. In most cases, vaccines need a suitable adjuvant and delivery carrier to trigger an adequate immune response. However, the availability of veterinary vaccine adjuvants and carriers is limited. Therefore, it is urgent to formulate novel strategies to develop safe and efficient adjuvants and vaccine delivery carriers to control various animal infectious diseases.
The aim of this Special Issue is to present research on the development and understanding of novel adjuvants and vaccine delivery carriers for emerging and re-emerging infectious diseases in various livestock. The following research themes are welcome:
- Novel adjuvants for veterinary vaccines
- Novel vaccine delivery carriers
- Understanding the underlying molecular mechanisms of novel vaccine adjuvants and delivery carriers
Prof. Dr. Wei Xu
Prof. Dr. Kai Zhao
Prof. Dr. Huichen Guo
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Vaccines is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- veterinary vaccines
- vaccine delivery carriers
- novel adjuvants
